Formulation containing anti-inflammatory androstane derivative | Patent Number 06858596

US 06858596 B2
Application Number10067020
Publication NumberUS 20020165211 A1
Pendency3 years, 19 days
Filled DateFeb 4, 2002
Priority DateAug 3, 2001
Publication DateNov 7, 2002
Expiration DateAug 3, 2021
Inventor/ApplicantsAmyn Pyarali Sayani
Ian Richard Buxton
Keith Biggadike
Amyn Pyarali Sayani
Keith Biggadike
Kenton Lewis Reed
Ian Richard Buxton
Kenton Lewis Reed
ExaminesBADIO, BARBARA P
Art Unit1616
Technology Center1600
Assignments
Glaxosmithkline Intellectual Property Development Limited
Current
Smithkline Beecham Corporation
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.